Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of ramosetron for prevention of postoperative nausea and vomiting in oxycodone-based IV PCA after gynecologic laparoscopic surgery
KCT0001745Phase 4Completed
- Sponsor
- Soonchunhyang University Cheonan Hospital
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ramosetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Soonchunhyang University Cheonan Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Apr 2014; status: completed.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on KCT0001745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001745.